(Q43235146)

16 November 2017

title

Ethnic differences in the population pharmacokinetics and pharmacodynamics of warfarin (English)

1 reference

16 November 2017

1 reference

1 reference

1

1 reference

16 November 2017

Ivelina Gueorguieva

2

1 reference

16 November 2017

Stephen Wise

series ordinal

3

1 reference

16 November 2017

Danny Soon

series ordinal

4

1 reference

16 November 2017

Leon Aarons

series ordinal

5

1 reference

16 November 2017

language of work or name

1 reference

26 November 2009

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

16 November 2017

published in

1 reference

16 November 2017

volume

37

1 reference

16 November 2017

issue

1

1 reference

16 November 2017

page(s)

3-24

1 reference

Cyclic interconversion of vitamin K1 and vitamin K1 2,3-epoxide in man.

16 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-009-9138-4

Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-009-9138-4

Physiological parameter values for physiologically based pharmacokinetic models

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10928-009-9138-4

Vitamin K1, vitamin K1 epoxide and warfarin interrelationships in the dog

21 January 2018

1 reference

12 December 2020

Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose

1 reference

12 December 2020

Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population

1 reference

12 December 2020

Effect of warfarin on plasma and liver vitamin K levels and vitamin K epoxide reductase activity in relation to plasma clotting factor levels in rats

1 reference

12 December 2020

VKORCI haplotypes and their impact on the inter-individual and inter-ethnical variability of oral anticoagulation

1 reference

12 December 2020

Bayesian analysis of population PK/PD models: general concepts and software

1 reference

12 December 2020

Influence of APOE genotypes and VKORC1 haplotypes on warfarin dose requirements in Asian patients

1 reference

12 December 2020

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

1 reference

12 December 2020

Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans

1 reference

12 December 2020

Investigation of the Effects of Herbal Medicines on Warfarin Response in Healthy Subjects: A Population Pharmacokinetic-Pharmacodynamic Modeling Approach

1 reference

12 December 2020

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

12 December 2020

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population

1 reference

12 December 2020

Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians

1 reference

12 December 2020

Effect of exenatide on the pharmacokinetics and pharmacodynamics of warfarin in healthy Asian men.

1 reference

12 December 2020

Dosage and control of oral anticoagulants: an international collaborative survey

1 reference

12 December 2020

Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity

1 reference

12 December 2020

A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9.

1 reference

12 December 2020

Changes in plasma protein binding have little clinical relevance

1 reference

12 December 2020

Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose

1 reference

12 December 2020

Cytochrome P450 polymorphisms are associated with reduced warfarin dose

1 reference

12 December 2020

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

1 reference

12 December 2020

Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model.

1 reference

12 December 2020

The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

1 reference

12 December 2020

Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

1 reference

12 December 2020

Genetic mechanisms for hypersensitivity and resistance to the anticoagulant Warfarin

1 reference

12 December 2020

Mixture models and subpopulation classification: a pharmacokinetic simulation study and application to metoprolol CYP2D6 phenotype

1 reference

12 December 2020

Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0 and 3.0.

1 reference

12 December 2020

Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone

1 reference

12 December 2020

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

1 reference

12 December 2020

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose

1 reference

12 December 2020

Identification of the gene for vitamin K epoxide reductase

1 reference

12 December 2020

Reversible metabolism of vitamin K-vitamin K epoxide: modeling considerations and limitations

1 reference

12 December 2020

10.1007/S10928-009-9138-4

Identifiers

DOI

1 reference

16 November 2017

1 reference